PhD, Johns Hopkins Bloomberg School of Public Health, 2004
ScM, Johns Hopkins Bloomberg School of Public Health, 1999
MHS, Johns Hopkins Bloomberg School of Public Health, 1999
BS, University of California, San Diego, 1997
My research interests include epidemiological and statistical methods for cohort (both clinical and interval) studies and application of these methods primarily to HIV cohort studies. I have specific interest in developing new methods as well as adapting approaches from other fields as novel solutions to specific epidemiologic questions. Examples include competing risk methodologies and extension to comparing multiple event types, random forests, bootstrap model averaging and multimodel inference
Dr. Lau is involved with multiple ongoing studies including the North American AIDS Cohort Collaboration of Research and Design (NA-ACCORD), an International Epidemiologic Databases to Evaluate AIDS [IeDEA] initiative sponsored by NIAID), the Johns Hopkins HIV Clinical Cohort Study, the ALIVE Study, the CFAR Network of Integrated Clinical Systems (CNICS), is a co-director for Biostatistics and Epidemiology Methods Core of the Johns Hopkins CFAR, and in addition collaborates with many other investigators across the University.
Honors and Awards
2016 Editor’s Choice for: Buchacz K, Lau B, Jing Y, et al. Incidence of AIDS-Defining Opportunistic Infections in a Multicohort Analysis of HIV-infected Persons in the United States and Canada, 2000-2015. Journal of Infectious Diseases 2016; 214:862-872. doi: 10.1093/infdis/jiw085
2015 Editor’s Choice for: Cole SR, Lau B, Eron JJ, et al. Estimation of the standardized Risk Difference and Ratio in a Competing Risks Framework: Application to Injection Drug Use and Progression to AIDS After Initiation of Antiretroviral Therapy. American Journal of Epidemiology 2015; 181:238-245.
2013 Inducted into Delta Omega Honorary Society in Public Health, Alpha Chapter, Johns Hopkins Bloomberg School of Public Health
2012 Editor’s Choice for: Silverberg MJ, Lau B, Justice AC, et al. Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America. Clin Infect Dis 2012;54:1026-1034